Multiomic characterization of response and resistance to neoadjuvant chemoradiotherapy in esophageal squamous cell carcinoma. [PDF]
Li Y +6 more
europepmc +1 more source
Angiotensin inhibitors during neoadjuvant chemotherapy improve esophageal squamous cell carcinoma outcomes. [PDF]
Chen M +8 more
europepmc +1 more source
Optimal management of potentially curable esophageal squamous cell carcinoma: what are the pillars of therapy? [PDF]
Ronellenfitsch U, Lordick F, Kleeff J.
europepmc +1 more source
Role of DDX39A in modulating the tumor progression and radiosensitivity in esophageal squamous cell carcinoma. [PDF]
Hui B +7 more
europepmc +1 more source
Sequential Esophageal Squamous Cell Carcinoma and Small Cell Carcinoma Following Prior Nissen Fundoplication. [PDF]
Babadi M +5 more
europepmc +1 more source
The consensus molecular subtypes of esophageal squamous cell carcinoma. [PDF]
Cui H +33 more
europepmc +1 more source
[Expression of Concern] Involvement of Cyr61 in the growth, invasiveness and adhesion of esophageal squamous cell carcinoma cells. [PDF]
Xie JJ +6 more
europepmc +1 more source
Preliminary examination of noncoding mutations of esophageal squamous cell carcinoma in African Americans. [PDF]
Erkizan HV, Wadleigh R.
europepmc +1 more source
Neoadjuvant versus adjuvant chemoradiotherapy for resectable cT3-4a esophageal squamous cell carcinoma: A matched cohort analysis. [PDF]
Lin M, Yu Y, Hu Y, Zheng R, Li J, Yao Q.
europepmc +1 more source
Metformin Use and Development of Esophageal Squamous Cell Carcinoma.
Xie SH +6 more
europepmc +1 more source

